rabipur
seqirus (nz) ltd - rabies vaccine 2.5 [iu] - injection with diluent - 2.5 iu - active: rabies vaccine 2.5 [iu] excipient: disodium edetate potassium l-glutamate polygeline sodium chloride sucrose trometamol water for injection - active immunisation against rabies virus, including (a) pre-exposure immunisation, (b) post-exposure treatment following exposure to rabies virus
rabies vaccine inactivated dried powder for solution
aventis pasteur limited - rabies vaccine inactivated (human diploid-cell culture) - powder for solution - 2.5unit - rabies vaccine inactivated (human diploid-cell culture) 2.5unit - vaccines
rabipur rabies virus vaccine (inactivated) 2.5 iu powder for injection vial with diluent ampoule
glaxosmithkline australia pty ltd - rabies virus -
inactivated rabies vaccine merieux hdcv inj. sol. (pwdr. + solv.) i.m. vial + pre-filled syr.
sanofi pasteur europe s.a. - rabies virus (inactivated) ; albumin human 50 mg - powder and solvent for solution for injection - rabies virus, inactivated - rabies, inactivated, whole virus
nobivac rabies inj. susp. i.m./s.c. vial
intervet international b.v. - rabies virus (inactivated) >= 2 iu/dose - suspension for injection - rabies virus, inactivated - rabies virus - cattle; dog; horse; cat; sheep
imogam rabies pasteurized human rabies immunoglobulin 150 iu/ml injection vial
sanofi-aventis australia pty ltd - rabies immunoglobulin, quantity: 150 iu/ml - injection - excipient ingredients: glycine; sodium chloride; water for injections - imogam rabies pasteurized is indicated in subjects who are thought to have been exposed to rabies virus, especially cases of major exposure, in accordance with w.h.o. recommendations as specified in the international product information.
menveo
gsk vaccines s.r.l. - meningococcal group a, c, w-135 and y conjugate vaccine - immunization, meningitis, meningococcal - bacterial vaccines - prefilled syringe menveo is indicated for active immunisation of adolescents (from 11 years of age) and adults at risk of exposure to neisseria meningitidis groups a, c, w135 and y, to prevent invasive disease. the use of this vaccine should be in accordance with official recommendations. vials menveo is indicated for active immunisation of children (from two years of age), adolescents and adults at risk of exposure to neisseria meningitidis groups a, c, w135 and y, to prevent invasive disease. the use of this vaccine should be in accordance with official recommendations.,
kamrab
kamada ltd, israel - human-rabies immunoglobulin - solution for injection - human-rabies immunoglobulin 150 iu/ml - rabies immunoglobulin - rabies immunoglobulin - kamrab im is indicated for passive, transient post-exposure prevention of rabies infection when given immediately to individuals in cases of contact with rabid or possibly rabid animal.
nobivac rabies
intervet ireland limited - rabies virus strain pasteur riv inactivated - suspension for injection - unknown - rabies virus vaccine - canine, feline - immunological - inactivated vaccine
imogam rabies pasteurized solution
sanofi pasteur limited - rabies immunoglobulin (human) - solution - 150unit - rabies immunoglobulin (human) 150unit - serums